Obesity and contraception: Emerging issues

Seminars in Reproductive Medicine

Volumn 28, Issue 2, 2010, Pages 156-163

  Murthy, Amitasrigowri S ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bariatric surgery; Contraception; Efficacy; Obesity; Pregnancy; Unplanned

Indexed keywords

ANTICOAGULANT AGENT; GESTAGEN; INJECTABLE CONTRACEPTIVE AGENT;

BARIATRIC SURGERY; BARRIER CONTRACEPTION; BIRTH CONTROL; CONTRACEPTION; DIET RESTRICTION; FEMALE STERILIZATION REVERSAL; GASTRIC BANDING; GASTROPLASTY; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; LIFESTYLE MODIFICATION; OBESITY; ORAL CONTRACEPTION; REVIEW; TRANSDERMAL PATCH; VAGINA RING; VENOUS THROMBOEMBOLISM;

BARIATRIC SURGERY; CONTRACEPTION; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; FERTILITY; HUMANS; OBESITY; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 77950541320     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0030-1248141     Document Type: Review

References (62)

1. Finer L B., Henshaw S K. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health 2006 38 (2) 90-96
2. World Health Report 2002. Overweight, obesity and high body mass, p. 60. Available at: http://www.who.int/whr/2002/en/whr02-en.pdf Accessed September 19, 2009
3. Mansour D. Implications of the growing obesity epidemic on contraception and reproductive health. J Fam Plann Reprod Health Care 2004 30 (4) 209-211
4. Society of Family Planning. Clinical guidelines. Contraceptive considerations in obese women. Contraception 2009 80 (6) 583-590
5. Packianathan I, Finer N. Medical consequences of obesity. Medicine 2003 31 (4) 8-12
6. Ogden C L., Yanovski S Z., Carroll M D., Flegal K M. The epidemiology of obesity. Gastroenterology 2007 132 2087-2102
7. Nelson S M., Fleming R. Obesity and reproduction: impact and interventions. Curr Opin Obstet Gynecol 2007 19 (4) 384-389
8. Lash M M., Armstrong A. Impact of obesity on women's health. Fertil Steril 2009 91 (5) 1712-1716
9. Bianchini F, Kaaks R, Vainio H. Overweight, obesity, and cancer risk. Lancet Oncol 2002 3 (9) 565-574
10. Wuntakal R, Hollingworth T. The implications of obesity on pregnancy. Obstet Gynecol Reprod Med 2009 19 (12) 344-359
11. Bray G A. Epidemiology risks and pathogenesis of obesity. Meat Sci 2005 71 2-7
12. Brunner Huber L R., Toth J L. Obesity and oral contraceptive failure: findings from the 2002 National Survey of Family Growth. Am J Epidemiol 2007 166 (11) 1306-1311
13. Kaneshiro B, Edelman A, Carlson N, Nichols M, Jensen J. The relationship between body mass index and unintended pregnancy: results from the 2002 National Survey of Family Growth. Contraception 2008 77 (4) 234-238
14. Irvine L M., Shaw R W. The effects of patient obesity in gynecological practice. Curr Obstet Gynaecol 2003 13 (3) 179-184
15. Fraser R B. Obesity complicating pregnancy. Curr Obstet Gynaecol 2006 16 (5) 295-298
16. Practice Committee of American Society for Reproductive Medicine. Obesity and reproduction: an educational bulletin. Fertil Steril 2008 90 (5, suppl) S21-S29
17. Grimes D A., Shields W C. Family planning for obese women: challenges and opportunities. Contraception 2005 72 (1) 1-4
18. Holt V L., Cushing-Haugen K L., Daling J R. Body weight and risk of oral contraceptive failure. Obstet Gynecol 2002 99 (5 Pt 1) 820-827
19. Holt V L., Scholes D, Wicklund K G., Cushing-Haugen K L., Daling J R. Body mass index, weight, and oral contraceptive failure risk. Obstet Gynecol 2005 105 (1) 46-52
20. Brunner Huber L R., Hogue C J., Stein A D., Drews C, Zieman M. Body mass index and risk for oral contraceptive failure: a case-cohort study in South Carolina. Ann Epidemiol 2006 16 (8) 637-643
21. Zhang H F., LaGuardia K D., Creanga D L. Higher body weight and body mass index are not associated with reduced efficacy in Ortho Tri-Cyclen Lo users [abstract]. Obstet Gynecol 2006 107 50S
22. Westhoff C, Reape K, Hait H. Subject weight and oral contraceptive efficacy in recent clinical trials. Contraception 2008 78 167
23. Burkman R T., Fisher A C., Wan G J., Barnowski C E., LaGuardia K D. Association between efficacy and body weight or body mass index for two low-dose oral contraceptives. Contraception 2009 79 (6) 424-427
24. Westhoff C, Torgal A, Mayeda E R., Lerner J, Paik M. Ovarian suppression during oral contraceptive use in normal-weight and obese women. Poster presented at: Annual Meeting of the Association of Reproductive Health Professionals October 1, 2009 Los Angeles, CA
25. Westhoff C, Reape K, Shu H. Impact of body weight on observed pregnancy rates with a low dose estrogen, 91-day extended regimen oral contraceptive. Oral abstract presented at: Annual Meeting of the Association of Reproductive Health Professionals October 1, 2009 Los Angeles, CA
26. Trussell J, Schwarz E B., Guthrie K. Obesity and oral contraceptive pill failure. Contraception 2009 79 (5) 334-338
27. Edelman A B., Carlson N E., Cherala G et al. Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity. Contraception 2009 80 (2) 119-127
28. Zieman M, Guillebaud J, Weisberg E, Shangold G A., Fisher A C., Creasy G W. Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data. Fertil Steril 2002 77 (2, suppl 2) S13-S18
29. Abrams L S., Skee D, Natarajan J, Wong F A. Pharmacokinetic overview of Ortho Evra/Evra. Fertil Steril 2002 77 (2, suppl 2) S3-S12
30. Dieben T O., Roumen F J., Apter D. Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring. Obstet Gynecol 2002 100 (3) 585-593
31. Westhoff C. Higher body weight does not affect NuvaRing's efficacy [abstract]. Obstet Gynecol 2005 105 (suppl 4) 56S
32. Bjarnadttir R I., Tuppurainen M, Killick S R. Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinyl estradiol. Am J Obstet Gynecol 2002 186 (3) 389-395
33. Cibula D, Hill M, Fanta M, Sindelka G, Zivny J. Does obesity diminish the positive effect of oral contraceptive treatment on hyperandrogenism in women with polycystic ovarian syndrome? Hum Reprod 2001 16 (5) 940-944
34. Rowland A S., Baird D D., Long S et al. Influence of medical conditions and lifestyle factors on the menstrual cycle. Epidemiology 2002 13 (6) 668-674
35. Hampton R M., Zhang H F., Barnowski C, Wan G J. Bleeding patterns with monophasic and triphasic low-dose ethinyl estradiol combined oral contraceptives. Contraception 2008 77 (6) 415-419
36. Curtis K M., Ravi A, Gaffield M L. Progestogen-only contraceptive use in obese women. Contraception 2009 80 (4) 346-354
37. Dinger J, Cronin M, Mohner S, Schellschimidt I, Minh T, Westhoff C. Oral contraceptive effectiveness according to body mass index, weight, age and other factors (EURAS-OC). Am J Obstet Gynecol 2009 201 (3) 263
38. Kaunitz A M., Darney P D., Ross D, Wolter K D., Speroff L. Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density. Contraception 2009 80 (1) 7-17
39. Bonny A E., Ziegler J, Harvey R, Debanne S M., Secic M, Cromer B A. Weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive method. Arch Pediatr Adolesc Med 2006 160 (1) 40-45
40. Graesslin O, Korver T. The contraceptive efficacy of Implanon: a review of clinical trials and marketing experience. Eur J Contracept Reprod Health Care 2008 13 (suppl 1) 4-12
41. Hubacher D, Grimes D A. Noncontraceptive health benefits of intrauterine devices: a systematic review. Obstet Gynecol Surv 2002 57 (2) 120-128
42. Kadir R A., Chi C. Levonorgestrel intrauterine system: bleeding disorders and anticoagulant therapy. Contraception 2007 75 (6, suppl) S123-S129
43. Seidell J C. Epidemiology of obesity. Semin Vasc Med 2005 5 (1) 3-14
44. Jamieson D J., Hillis S D., Duerr A, Marchbanks P A., Costello C, Peterson H B. Complications of interval laparoscopic tubal sterilization: findings from the United States Collaborative Review of Sterilization. Obstet Gynecol 2000 96 (6) 997-1002
45. Maggard M A., Yermilov I, Li Z et al. Pregnancy and fertility following bariatric surgery: a systematic review. JAMA 2008 300 (19) 2286-2296
46. Guelinckx I, Devlieger R, Vansant G. Reproductive outcome after bariatric surgery: a critical review. Hum Reprod Update 2009 15 (2) 189-201
47. Tice J A., Karliner L, Walsh J, Petersen A J., Feldman M D. Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures. Am J Med 2008 121 (10) 885-893
48. Merhi Z O. Challenging oral contraception after weight loss by bariatric surgery. Gynecol Obstet Invest 2007 64 (2) 100-102
49. Gerrits E G., Ceulemans R, van Hee R, Hendrickx L, Tott E. Contraceptive treatment after biliopancreatic diversion needs consensus. Obes Surg 2003 13 (3) 378-382
50. Krishnan S, Hacker M, Haider S et al. Contraceptive counseling and utilization in women who underwent bariatric surgery. Poster presented at: Annual Meeting of the Association of Reproductive Health Professionals October 1, 2009 Los Angeles, CA
51. American College of Obstetricians and Gynecologists Practice Bulletin. Use of hormonal contraception in women with coexisting medical conditions. In: Clinical Management Guidelines for Obstetricians-Gynecologists. Number 73 Washington, DC American College of Obstetricians and Gynecologists June 2006
52. Culwell K R., Curtis K M. Use of contraceptive methods by women with current venous thrombosis on anticoagulant therapy: a systematic review. Contraception 2009 80 (4) 337-345
53. Snmezer M, Atabekolu C, Cengiz B, Dkmeci F, Cengiz S D. Depot-medroxyprogesterone acetate in anticoagulated patients with previous hemorrhagic corpus luteum. Eur J Contracept Reprod Health Care 2005 10 (1) 9-14
54. Goldstein J, Cushman M, Badger G J., Johnson J V. Effect of depomedroxyprogesterone acetate on coagulation parameter: a pilot study. Fertil Steril 2007 87 (6) 1267-1270
55. Samsioe G. Coagulation and anticoagulation effects of contraceptive steroids. Am J Obstet Gynecol 1994 170 (5 Pt 2) 1523-1527
56. Rosendaal F R., Van Hylckama Vlieg A, Tanis B C., Helmerhorst F M. Estrogens, progestogens and thrombosis. J Thromb Haemost 2003 1 (7) 1371-1380
57. Rosendaal F R., Helmorhorst F M., Vandenbroucke J P. Female hormones and thrombosis. Arterioscler Thromb Vasc Biol 2002 22 201-210
58. Conard J. Biological coagulation findings in third-generation oral contraceptives. Hum Reprod Update 1999 5 (6) 672-680
59. Martnez F, Avecilla A. Combined hormonal contraception and venous thromboembolism. Eur J Contracept Reprod Health Care 2007 12 (2) 97-106
60. Lawrenson R, Farmer R. Venous thromboembolism and combined oral contraceptives: does the type of progestogen make a difference? Contraception 2000 62 (2, suppl) 21S-28S; discussion 37S38S
61. Abdollahi M, Cushman M, Rosendaal F R. Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use. Thromb Haemost 2003 89 (3) 493-498
62. Pomp E R., le Cessie S, Rosendaal F R., Doggen C J. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. Br J Haematol 2007 139 289-296